Skip to search boxSkip to navigationSkip to main content

Clear cell adenocarcinoma of the lung: A SEER analysis

  • Takefumi Komiya(corresponding author)
    ,
  • Achuta Kumar Guddati
    ,
  • Yukihiro Nakanishi
*Corresponding author for this work
  • Parkview Cancer Institute
    ,
  • ,
  • Tulane University
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

<p>Clear cell adenocarcinoma (CCA) in lung has been considered as a rare subtype of lung adenocarcinoma. However, recent classifications of lung adenocarcinoma proposed to discontinue CCA due to lack of available data with clinical significance. Patients with CCA and lung adenocarcinoma not otherwise specified (LANOS) were queried from The Surveillance, Epidemiology, and End Results Program (SEER) database. Cancer-specific survival was studied according to gender (male, female), age (0–69, 70+), SEER specific stage A system (localized, regional and distant), year of diagnosis (1973–2000, 2001–2013), surgery (yes, no), and radiation therapy (yes, no) using Kaplan-Meier curves. Multivariate analysis was used to study independent predictors of cancer-specific survival. A total of 1,227 and 233,154 patients with the diagnosis of CCA and LANOS respectively were found in the SEER database. CCA histology was significantly associated with an early year of diagnosis, younger age, early stage, surgery, and lack of radiation. Kaplan-Meier curves showed that patients with CCA histology had significantly better cancer-specific survival (P<0.0001, Log-Rank). Subset analysis demonstrated the difference in cancer-specific survival between CCA and NOS histology was significant in localized and regional but not distant stage disease (P=0.0453, 0.0009, 0.0664, respectively). Patients with CCA histology have superior survival in the locoregional stage according to our SEER analysis, suggesting its unique role in prognosis despite it being removed from recent pathologic classifications.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 187-191 (5 pages)

Journal (Volume, Issue Number)

Translational Lung Cancer Research (Volume 8, Issue 2)

Publication milestones

  • Published - 04/01/2019

Publication status

Published - 04/01/2019

ISSN

2218-6751

Publication IDs

  • Scopus: 85065207807

Publication metrics

Metrics

SciVal
FWCI
0.27
SciVal
Author count
3
SciVal
citations
2
SciVal
Paper percentile
59
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
8
Citation count
10